vimarsana.com

Latest Breaking News On - Ingrid delaet - Page 8 : vimarsana.com

Aurora Investment Counsel Sells 124 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX)

Aurora Investment Counsel Sells 124 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United-states
Ingrid-delaet
Neurocrine-biosciences
Kevin-charles-gorman
Neurocrine-biosciences-inc
Citigroup
Holdings-channel
Mercer-global-advisors-inc
Barclays
Canaccord-genuity-group
Meiji-yasuda-asset-management-co-ltd
Securities-exchange-commission

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Receives $131.46 Average PT from Analysts

Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the twenty-one research firms that are currently covering the company, MarketBeat.com reports. Five research analysts have rated the stock with a hold recommendation and sixteen have given a buy recommendation to the company. The average 1 year […]

Canada
United-states
America
Davidw-boyer
Ingrid-delaet
Neurocrine-biosciences
Royal-bank
Hightower-advisors
Nasdaq
Neurocrine-biosciences-company-profile
Acadian-asset-management
Neurocrine-biosciences-inc

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Given Average Recommendation of "Moderate Buy" by Brokerages

Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Free Report) have been given an average rating of “Moderate Buy” by the twenty-one analysts that are presently covering the company, MarketBeat Ratings reports. Five research analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company. The average […]

Canada
Davidw-boyer
Neurocrine-biosciences
Ingrid-delaet
Bluepath-capital-management
Nasdaq
Royal-bank
Acadian-asset-management
Covestor-ltd
Bessemer-group-inc
Neurocrine-biosciences-company-profile
Neurocrine-biosciences-inc

Prosight Management LP Invests $8.10 Million in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)

Prosight Management LP bought a new position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) during the first quarter, according to the company in its most recent filing with the SEC. The firm bought 80,000 shares of the company’s stock, valued at approximately $8,098,000. Neurocrine Biosciences accounts for approximately 3.8% of Prosight Management LP’s investment […]

Jude-onyia
Robertw-baird
Neurocrine-biosciences
Ingrid-delaet
Bessemer-group-inc
Cantor-fitzgerald
Jefferies-financial-group
Neurocrine-biosciences-inc
Acadian-asset-management
Securities-exchange-commission
Nasdaq
Covestor-ltd

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the twenty-one analysts that are presently covering the stock, MarketBeat.com reports. Five analysts have rated the stock with a hold recommendation and sixteen have assigned a buy recommendation to the company. The average 1 year price objective […]

Mizuho
Sakhalinskaya-oblast
Russia
Canada
Ingrid-delaet
Neurocrine-biosciences
Davidw-boyer
Bessemer-group-inc
Acadian-asset-management
Nasdaq
Covestor-ltd
Neurocrine-biosciences-company-profile

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.